Is postmastectomy radiotherapy necessary for breast cancer patients with clinically node-positive downstaging to ypN0 after neoadjuvant chemotherapy?
Chen-Feng TanJun WangXiao-Rong ZhongZe-Lei DaiZhong-Zheng XiangYuan-Yuan ZengXiao-Yuan WeiNing-Yue XuLei LiuPublished in: Breast cancer research and treatment (2024)
In the context of comprehensive treatments, PMRT might be exempted in ypN0 breast cancer patients. Further large-scale, randomized controlled studies are required to investigate the significance of PMRT in this patient subset.